{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,12]],"date-time":"2026-03-12T02:18:10Z","timestamp":1773281890649,"version":"3.50.1"},"reference-count":31,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[1998,1,1]],"date-time":"1998-01-01T00:00:00Z","timestamp":883612800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[1998,1,1]],"date-time":"1998-01-01T00:00:00Z","timestamp":883612800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Int Ophthalmol"],"published-print":{"date-parts":[[1998,1]]},"DOI":"10.1023\/a:1006176713983","type":"journal-article","created":{"date-parts":[[2002,12,22]],"date-time":"2002-12-22T00:53:09Z","timestamp":1040518389000},"page":"37-42","source":"Crossref","is-referenced-by-count":29,"title":["Additive effect of latanoprost and dorzolamide in patients with elevated intraocular pressure"],"prefix":"10.1007","volume":"22","author":[{"given":"Mustafa","family":"Kemal Arici","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ay\u015fen","family":"Topalkara","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cenap","family":"G\u00fcler","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"189041_CR1","doi-asserted-by":"crossref","first-page":"1035","DOI":"10.3109\/02713688709034874","volume":"6","author":"K Crawford","year":"1987","unstructured":"Crawford K, Kaufman L, Gabelt BT. Effect of topical PGF2aon aqueous humor dynamics in cynomogus monkeys. Curr Eye Res 1987; 6: 1035-1044.","journal-title":"Curr Eye Res"},{"key":"189041_CR2","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1016\/0014-4835(90)90174-S","volume":"51","author":"BT Gabelt","year":"1990","unstructured":"Gabelt BT, Kaufman PL. The effect of prostaglandin F2a on trabecular outflow facility in cynomolgus monkeys. Exp Eye Res 1990; 51: 87-91.","journal-title":"Exp Eye Res"},{"key":"189041_CR3","first-page":"2466","volume":"31","author":"RF Wang","year":"1990","unstructured":"Wang RF, Camras CB, Lee PY, Podos SM, Bito LZ. Effects of prostaglandis F2a, A2, and their esters in glaucomatous monkey eyes. Invest Ophthalmol Vis Sci 1990; 31: 2466-2470.","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"189041_CR4","first-page":"349","volume":"312","author":"LZ Bito","year":"1989","unstructured":"Bito LZ, Camras CB, Gum GG, Resul B. The ocular hypotensive effects and side effects of prostaglandins on the eyes of experimental animals. Prog Clin Biol Res 1989; 312: 349-368.","journal-title":"Prog Clin Biol Res"},{"key":"189041_CR5","first-page":"369","volume":"312","author":"PF Hoyng","year":"1989","unstructured":"Hoyng PF, Groeneboer MC. The effects of prostacyclin and its stable analog on intraocular pressure. Prog Clin Biol Reg 1989; 312: 369-378.","journal-title":"Prog Clin Biol Reg"},{"key":"189041_CR6","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1016\/0002-9394(88)90117-1","volume":"105","author":"JR Kerstetter","year":"1988","unstructured":"Kerstetter JR, Brubaker RF, Wilson SE, Kullerstrant U. Prostaglandin F2a-1-isopropylester lowers intraocular pressure without decreasing aqueous humor flow. Am J Ophthalmol 1988; 105: 30-34.","journal-title":"Am J Ophthalmol"},{"key":"189041_CR7","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1136\/bjo.73.6.419","volume":"73","author":"J Villumsen","year":"1989","unstructured":"Villumsen J, Alm A. Prostaglandin F2a-isopropylester eye drops: Effect in normal human eyes. Br J Ophthalmol 1989; 73: 419-426.","journal-title":"Br J Ophthalmol"},{"key":"189041_CR8","doi-asserted-by":"crossref","first-page":"1329","DOI":"10.1016\/S0161-6420(89)32717-5","volume":"96","author":"CB Camras","year":"1989","unstructured":"Camras CB, Siebold EC, Luntgarten JS, Serle JB, Frisch SC, Podos SM, et al. Maintained reduction of intaocular pressure by prostaglandin F2a-1-isopropyl ester applied in multiple doses in ocular hypertensive and glaucoma patients. Opthalmology 1989; 96:1329-1336.","journal-title":"Opthalmology"},{"key":"189041_CR9","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1007\/BF02173538","volume":"222","author":"G. Guiffre","year":"1985","unstructured":"Guiffre G. The effects of prostaglandin F2 in the human eye. Graefes Arch Clin Exp Ophthalmol 1985; 222:139-141.","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"key":"189041_CR10","doi-asserted-by":"crossref","first-page":"1564","DOI":"10.1001\/archopht.1991.01080110100045","volume":"109","author":"A Alm","year":"1991","unstructured":"Alm A, Villumsen J. PhXA34, a new potent ocular hypotensive drug. A study on dose-response relationship and on aqueous humor dynamics in healthy volunteers. Arch Ophthalmol 1991; 109:1564-1568.","journal-title":"Arch Ophthalmol"},{"key":"189041_CR11","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1136\/bjo.76.4.214","volume":"762","author":"J Villumsen","year":"1992","unstructured":"Villumsen J, Alm A. PhXA34-a prostaglandin F2a analogue. Effect on intraocular pressure in with ocular hypertension. Br J Ophthalmol 1992; 762 214-217.","journal-title":"Br J Ophthalmol"},{"key":"189041_CR12","doi-asserted-by":"crossref","first-page":"1312","DOI":"10.1016\/S0161-6420(93)31482-X","volume":"100","author":"A Alm","year":"1993","unstructured":"Alm A, Villumsen J, T\u00f6rnquist P., Mandahl A, Airaksinen J, Tuulonen A, Marks A, Resul B, Stjerschantz J. Intraocular pressure-reducing effect of PhXA41 in patients with increased eye pressure. A one-month study. Ophthalmology 1993; 100: 1312-1317.","journal-title":"Ophthalmology"},{"key":"189041_CR13","doi-asserted-by":"crossref","first-page":"929","DOI":"10.1001\/archopht.1996.01100140137004","volume":"114","author":"HK Mishima","year":"1996","unstructured":"Mishima HK, Masuda K, Kitazava Y, Azuma I, Araie M. A comparison of latanoprost and timolol in primary open-angle glaucoma and ocular hypertension. Arch Ophthalmol 1996; 114: 929-932.","journal-title":"Arch Ophthalmol"},{"key":"189041_CR14","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1001\/archopht.1993.01090050091036","volume":"111","author":"P R\u00e1cz","year":"1993","unstructured":"R\u00e1cz P, Ruzsonyi MR, Nagy ZT, Bito L. Maintained intraocular pressure reduction with once-a-day application of a new prostaglandin F2a analogue (PhXa41). An in-hospital, placebo-controlled study. Arch Ophthalmol 1993; 111: 657-661.","journal-title":"Arch Ophthalmol"},{"key":"189041_CR15","doi-asserted-by":"crossref","first-page":"1351","DOI":"10.1001\/archopht.1993.01090100059027","volume":"111","author":"N Ziai","year":"1993","unstructured":"Ziai N, Dolan JW, Kacere RD, Brubaker RF. The effect on aqueous dynamics of PhXA41, a new prostaglandin F2aanalogue after topical application in normal and ocular hypertensive human eyes. Arch Opthalmol 1993; 111: 1351-1358.","journal-title":"Arch Opthalmol"},{"key":"189041_CR16","doi-asserted-by":"crossref","first-page":"1743","DOI":"10.1016\/S0161-6420(95)30798-1","volume":"102","author":"A Alm","year":"1995","unstructured":"Alm A, Stjernschantz J, The Scandinavian Latanoprost Study Group. Effects of intraocular pressure and side effects of 0.005% latanoprost applied once daily, evening or morning a comparison with timolol. Ophthalmology 1995; 102: 1743-1752.","journal-title":"Ophthalmology"},{"key":"189041_CR17","doi-asserted-by":"crossref","first-page":"1297","DOI":"10.1016\/S0161-6420(93)31484-3","volume":"100","author":"CB Toris","year":"1993","unstructured":"Toris CB, Camras CB, Yablonski MB. Effect of PhXA41, a new prostaglandin F2a analogue, on aqueous dynamics in human eyes. Ophthalmology 1993; 100: 1297-304.","journal-title":"Ophthalmology"},{"key":"189041_CR18","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1136\/bjo.79.1.12","volume":"79","author":"A Alm","year":"1995","unstructured":"Alm A, Widengard I, Kjellen D, S\u00f6derstr\u00f6m M, Fristr\u00f6m B, Heijil A, Stjerschantz J. Latanoprost administered once daily caused a maintained reduction of intraocular pressure in glaucoma patients treated concomitantly with timolol. Br J Ophthalmol 1995; 79: 12-16.","journal-title":"Br J Ophthalmol"},{"key":"189041_CR19","doi-asserted-by":"crossref","first-page":"1305","DOI":"10.1016\/S0161-6420(13)31817-X","volume":"100","author":"S Nagasubramanian","year":"1993","unstructured":"Nagasubramanian S, Sheth GP, Hitchings RA, Stjernschantz, J. Intraocular pressure-reducing effect of PhXA41 in ocular hypertension. comparison of dose regimens. Ophthalmology 1993 100: 1305-1311.","journal-title":"Ophthalmology"},{"key":"189041_CR20","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1016\/S0161-6420(96)30749-5","volume":"103","author":"CB Camras","year":"1996","unstructured":"Camras CB, The United States Latanoprost Study Group. Comparison of latanoprost and timolol in patients with ocular hypertension and glaucoma. Ophthalmology 1996; 103: 138-147.","journal-title":"Ophthalmology"},{"key":"189041_CR21","doi-asserted-by":"crossref","first-page":"1102","DOI":"10.1001\/archopht.1990.01070100058034","volume":"108","author":"J Villusen","year":"1990","unstructured":"Villusen J, Alm A. The effect of adding prostaglandin F2a-isopropylester to timolol in patients with open angle glaucoma. Arch Ophthalmol 1990; 108: 1102-1105.","journal-title":"Arch Ophthalmol"},{"key":"189041_CR22","doi-asserted-by":"crossref","first-page":"1079","DOI":"10.1016\/S0161-6420(91)32173-0","volume":"98","author":"PY Lee","year":"1991","unstructured":"Lee PY, Shao H, Camras CB, Podos SM. Additivity of prostaglandin prostaglandin F2a-isopropylester to timolol in glaucoma patients. Ophthalmology 1991; 98: 1079-1082.","journal-title":"Ophthalmology"},{"key":"189041_CR23","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1097\/00061198-199510000-00002","volume":"4","author":"R Laibovitz","year":"1995","unstructured":"Laibovitz R, Strahlman ER, Barber BL, Strohmaier KM. Comparison of quality of life and patient preference of dorzolamide and pilocarpine as adjunctive therapy to timolol in the treatment of glaucoma. Journal of Glaucoma 1995; 4: 306-313.","journal-title":"Journal of Glaucoma"},{"key":"189041_CR24","doi-asserted-by":"crossref","first-page":"1283","DOI":"10.1016\/S0161-6420(96)30509-5","volume":"103","author":"ER Strahlman","year":"1996","unstructured":"Strahlman ER, Vogel R, Tipping R, Clineschmidt CM, BA, The Dorzolamide Additivity Study Group. The use of dorzolamide and pilocarpine as adjunctive therapy to timolol in patients with elevated intraocular pressure. Ophthalmology 1996; 103: 1283-1293.","journal-title":"Ophthalmology"},{"key":"189041_CR25","doi-asserted-by":"crossref","first-page":"1503","DOI":"10.1016\/S0161-6420(97)30110-9","volume":"T04","author":"AH Rulo","year":"1997","unstructured":"Rulo AH, Greve EL, Hoyng PF. Additive ocular hypotensive effect of latanoprost and acetazolamide. A short-term study in patients with elevated intraocular pressure. Ophthalmology 1997; T04: 1503-1507.","journal-title":"Ophthalmology"},{"key":"189041_CR26","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1016\/S0161-6420(91)32295-4","volume":"98","author":"EA Lippa","year":"1991","unstructured":"Lippa EA, Schuman JS, Higginbotham EJ, Kass MA, Weinreb RN, Skuta GL, Epstein DL, Shaw B, Holder DJ, Deasy DA, Wilensky JT. MK-507 versus sezolamide. Comparative efficacy of two topical active carbonic anhydrase inhibitors. Ophthalmology 1991; 98: 308-313.","journal-title":"Ophthalmology"},{"key":"189041_CR27","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1001\/archopht.1992.01080160073033","volume":"110","author":"EA Lippa","year":"1992","unstructured":"Lippa EA, Carlson LE, Ehinger B, Eriksson LO, Finnstr\u00f6m K, Holmin C, Nilsson SE, Nyman K, Raitta C, Ringvold A, Tarkkanen A, Vegge T, Deasy D, Holder D, Ytteborg J. Dode. Response and duration of dorzolamide, a topical carbonic anhydrase inhibitor. Arch Ophthalmol 1992; 110: 495-499.","journal-title":"Arch Ophthalmol"},{"key":"189041_CR28","doi-asserted-by":"crossref","first-page":"1343","DOI":"10.1001\/archopht.1993.01090100051026","volume":"111","author":"M Wilkerson","year":"1993","unstructured":"Wilkerson M, Cyrlin M, Lippa EA, Esposito D, Deasy D, Panebianco D, Fazio R, Yablonski M, Shields B. Four-week safety and efficacy study of dorzolamide, a novel, active topical carbonic anhydrase inhibitor. Arch Ophthalmol 1993, 111: 1343-1350.","journal-title":"Arch Ophthalmol"},{"key":"189041_CR29","doi-asserted-by":"crossref","first-page":"1009","DOI":"10.1001\/archopht.1995.01100080061030","volume":"113","author":"E Strahlman","year":"1995","unstructured":"Strahlman E, Tipping R, Vogel R, and International Dorzolamide Study group. A double-masked, randomized 1 year study comparing dorzolamide (Trusopt), timolol, and betaxolol. Arch Ophthalmol 1995; 113: 1009-1016.","journal-title":"Arch Ophthalmol"},{"key":"189041_CR30","doi-asserted-by":"crossref","first-page":"899","DOI":"10.1136\/bjo.78.12.899","volume":"78","author":"AH Rulo","year":"1994","unstructured":"Rulo AH, Greve EL, Hoyng P. Additive effect of latanoprost, a prostaglandin F2a analogue, and timolol in patients with elevated intraocular pressure. Br J Ophthalmol 1994; 78: 899-902.","journal-title":"Br J Ophthalmol"},{"key":"189041_CR31","doi-asserted-by":"crossref","first-page":"662","DOI":"10.1001\/archopht.1993.01090050096037","volume":"111","author":"B Fristr\u00f6m","year":"1993","unstructured":"Fristr\u00f6m B, Nilson SEG. Interaction of PhXA41 a new prostaglandin analogue with pilocarpine. A study on patients with elevated intraocular pressure. Arch Ophthalmol 1993; 111: 662-665.","journal-title":"Arch Ophthalmol"}],"container-title":["International Ophthalmology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1023\/A:1006176713983.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1023\/A:1006176713983\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1023\/A:1006176713983.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,27]],"date-time":"2025-05-27T13:18:52Z","timestamp":1748351932000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1023\/A:1006176713983"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1998,1]]},"references-count":31,"journal-issue":{"issue":"1","published-print":{"date-parts":[[1998,1]]}},"alternative-id":["189041"],"URL":"https:\/\/doi.org\/10.1023\/a:1006176713983","relation":{},"ISSN":["0165-5701","1573-2630"],"issn-type":[{"value":"0165-5701","type":"print"},{"value":"1573-2630","type":"electronic"}],"subject":[],"published":{"date-parts":[[1998,1]]}}}